80 related articles for article (PubMed ID: 21726818)
1. Comorbidity in lung cancer: important but neglected. a review of the current literature.
Grose D; Devereux G; Milroy R
Clin Lung Cancer; 2011 Jul; 12(4):207-11. PubMed ID: 21726818
[TBL] [Abstract][Full Text] [Related]
2. Variation in comorbidity and clinical management in patients newly diagnosed with lung cancer in four Scottish centers.
Grose D; Devereux G; Brown L; Jones R; Sharma D; Selby C; Morrison DS; Docherty K; McIntosh D; Louden G; Downer P; Nicolson M; Milroy R;
J Thorac Oncol; 2011 Mar; 6(3):500-9. PubMed ID: 21258251
[TBL] [Abstract][Full Text] [Related]
3. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
4. Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations.
Stevens W; Stevens G; Kolbe J; Cox B
Intern Med J; 2008 Oct; 38(10):758-68. PubMed ID: 18298555
[TBL] [Abstract][Full Text] [Related]
5. Improved survival from lung cancer in British Columbia compared to Scotland-are different treatment rates the whole story?
Erridge SC; Murray B; Williams L; Brewster D; Black R; Price A; Murray N; Sheehan F
Lung Cancer; 2009 Jun; 64(3):358-66. PubMed ID: 19036470
[TBL] [Abstract][Full Text] [Related]
6. The need for a multidisciplinary approach to cancer care.
Ko C; Chaudhry S
J Surg Res; 2002 Jun; 105(1):53-7. PubMed ID: 12069502
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of lung cancer in Scotland: a review of trends in incidence, survival and mortality and prospects for prevention.
Sharp L; Brewster D
Health Bull (Edinb); 1999 Sep; 57(5):318-31. PubMed ID: 12811879
[TBL] [Abstract][Full Text] [Related]
8. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
9. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
[TBL] [Abstract][Full Text] [Related]
10. [Overall long-term survival in lung cancer analyzed in 610 unselected patients].
Sánchez de Cos Escuín J; Disdier Vicente C; Corral Peñafiel J; Riesco Miranda JA; Sojo González MA; Masa Jiménez JF
Arch Bronconeumol; 2004 Jun; 40(6):268-74. PubMed ID: 15161593
[TBL] [Abstract][Full Text] [Related]
11. Alcohol abuse predicts progression of disease and death in patients with lung cancer.
Paull DE; Updyke GM; Baumann MA; Chin HW; Little AG; Adebonojo SA
Ann Thorac Surg; 2005 Sep; 80(3):1033-9. PubMed ID: 16122481
[TBL] [Abstract][Full Text] [Related]
12. [Lung cancer in the Netherlands in the period 1989-1997: the epidemic is not over yet].
Janssen-Heijnen ML; van Dijck JA; Siesling S; Schipper RM; Damhuis RA
Ned Tijdschr Geneeskd; 2001 Mar; 145(9):419-23. PubMed ID: 11253497
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer survival in Spain and prognostic factors: a prospective, multiregional study.
de Cos JS; Miravet L; Abal J; Núñez A; Muñoz FJ; García L; Castañar AM; Montero MA; Hernández J; Alonso MA
Lung Cancer; 2008 Feb; 59(2):246-54. PubMed ID: 17889402
[TBL] [Abstract][Full Text] [Related]
14. Benchmarking the clinical prosthetic dental literature on MEDLINE.
Nishimura K; Rasool F; Ferguson MB; Sobel M; Niederman R
J Prosthet Dent; 2002 Nov; 88(5):533-41. PubMed ID: 12474005
[TBL] [Abstract][Full Text] [Related]
15. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival.
Tammemagi CM; Neslund-Dudas C; Simoff M; Kvale P
J Clin Epidemiol; 2004 Jun; 57(6):597-609. PubMed ID: 15246128
[TBL] [Abstract][Full Text] [Related]
16. Do racial or socioeconomic disparities exist in lung cancer treatment?
Yang R; Cheung MC; Byrne MM; Huang Y; Nguyen D; Lally BE; Koniaris LG
Cancer; 2010 May; 116(10):2437-47. PubMed ID: 20209616
[TBL] [Abstract][Full Text] [Related]
17. Differential prognostic impact of comorbidity.
Read WL; Tierney RM; Page NC; Costas I; Govindan R; Spitznagel EL; Piccirillo JF
J Clin Oncol; 2004 Aug; 22(15):3099-103. PubMed ID: 15284260
[TBL] [Abstract][Full Text] [Related]
18. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
19. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
Birim O; Kappetein AP; Bogers AJ
Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
[TBL] [Abstract][Full Text] [Related]
20. Pemetrexed: a multitargeted antifolate.
Rollins KD; Lindley C
Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
